CELLULITE: FOR DEFINITE RESULTS WITHIN THREE WEEKS

After three weeks your friends may not notice, but you will certainly notice the impact you have made on cellulite if you do all the following:

• Make a list of all the foods and drinks that you consume. Cut out the negative foods as best you can. Cut by 50% what you can’t cut out entirely.

• Put a curfew on all bad habits. Instead of smoking your first cigarette at 9.00am – save it until midday. If you drink your first alcoholic drink at 6.00pm – make that 9.00pm, etc.

• Eat unprocessed food, including fruit and vegetables. If you make a positive effort to enjoy such foods, you’ll lessen the negative emotions associated with ‘giving things up’. In fact, if you fill up on good food you’ll have less room for junk food, and naturally, eat less of it.

• Drink more water. Fluid gets rid of fluid. Water also carries oxygen around your body and therefore it feeds everything, especially the brain.

• Consider taking a course of herbal cellulite-loss tablets. Some useful ingredients to look for are Soya Lecithin (which helps break down fats), Ginkgo Biloba extract (which assists circulation and stimulates metabolism of fats) and Sweet Clover (which increases blood circulation and assists in removing fluid build-up). *

• Start with 15 minutes of exercise every day, increasing to 30 minutes per day when you feel that you can handle it.

What I have proposed is certainly not a strict program. It doesn’t require radical changes – just a little self-control. Yet it does yield results.

By stimulating your metabolism and exercising on a regular basis, you will start the reversal process, and no matter where the cellulite is – it will shift.

Comments

HYFRECATORS AND INTERFERENCE WITH IMPLANTABLE CARDIAC DEVICES

Investigation of Hyfrecators and They are In Vitro Interference with Implantable Cardiac Devices CHRISTOPHER WEYER, DO,* RONALD J. SIEGLE, MD,†‡ AND GUILLAUME GIRARD P. ENG, EMI-EMC§ BACKGROUND Guidelines exist for minimizing potential electromagnetic interference (EMI) with electrosurgical equipment in patients with cardiac rhythm management (CRM) devices. These guidelines encompass all electrosurgical devices but are not speciﬁc for hyfrecators. OBJECTIVE To investigate the potential interference of CRM devices by hyfrecators. MATERIALS AND METHODS Using a collagen-based saline gel, three implantable pulse generators (pacemakers) and three implantable cardioverter deﬁbrillators were tested to measure the EMI from two commonly used hyfrecators. The six devices were tested using the hyfrecator under normal use settings and on maximum power. RESULTS Hyfrecators did not interfere with deﬁbrillators and affected pacemakers only when used in close proximity to the devi...

NEW DRUG THERAPY FOR BCC

Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate. Vismodegib is an investigational, oral, targeted medicine designed to selectively inhibit signaling in the Hedgehog pathway, which is implicated in more than 90 percent of BCC cases. BCC is the most common type of skin cancer, which is generally considered curable by surgery. However, when it advances, BCC can cause disfiguring and debilitating effects and can ultimately be life-threatening. “We are excited by the pivotal study results that showed vismodegib substantially reduced tumor size or healed lesions for people with this rare skin cancer, which has no approved ...

TRANSACTION AND MELANOMA SURVIVAL

The rate of melanoma transaction with various biopsy techniques and the influence of tumor transaction on patient survival Mohsin Mir, MD, C. Stanley Chan, MD, Farhan Khan, MD, MBA, Bhuvaneswari Krishnan, MD, Ida Orengo, MD, and Theodore Rosen, MD Houston, Texas Background: Depth of melanoma invasion is critical because it dictates patient treatment and prognosis. Recent reports indicate melanoma transection with initial biopsy does not impact patient survival; however, tumor transaction can lead to misdiagnosis and inaccurate staging. Objective: This study assessed the rate of melanoma transaction with various biopsy techniques and the impact of tumor transaction on patient survival. Methods: We conducted a retrospective review of all melanoma cases at our institution between 2000 and 2008. Of the 490 melanoma cases identified, 479 met inclusion criteria for the study. The transaction rates of biopsy techniques were determined. Cases of transected ...

Skin Health

Search This Blog